The FDA on Friday said it approved Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of severe heart issues in overweight or obese adults.
Wegovy gets FDA approval to reduce risk of heart issues in overweight adults
Read Next
- 9 phrases men use when they have an above average level of emotional intelligence, says psychology
- If you want people to start genuinely enjoying your company, say goodbye to these 7 behaviors
- Senate review of Supreme Court ethics urges enforceable conduct code
- 9 signs someone isn’t actually nice, they’re a just a people-pleaser
- 6 types of family members who can be very difficult to live with, according to psychology
- If you really want to overcome your difficult childhood, say goodbye to these 7 habits
- HDFC Securities expects India GDP to moderate to 6.4% in 2024-25, ET BFSI
